Polatuzumab Vedotin

ATC L01FX14 · 9 markets · 19 records

Polatuzumab Vedotin 9 markets · 19 records Forms

AU 3 records · 3 strengths

140 mginjectionPOLIVY polatuzumab vedotin 140 mg powder for injection vial also in GB·SG·ES unknown
30 mginjectionPOLIVY polatuzumab vedotin 140 mg powder for injection vial also in GB·ES unknown

Records without a stated strength · 1 POLIVY

US 2 records · 2 strengths

140 mg/7.52 mLinjectionPOLIVY
30 mg/1.88 mLinjectionPOLIVY

GB 2 records · 2 strengths

140 mginjectionPolivy 140mg powder for concentrate for solution for infusion vials also in AU·SG·ES
30 mginjectionPolivy 140mg powder for concentrate for solution for infusion vials also in AU·ES

CA 2 records · 2 strengths

140 mgpowderPOLIVY
30 mgpowderPOLIVY

SG 2 records · 2 strengths

140 mginjectionPOLIVY POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 30MG also in AU·GB·ES
30 mg/vialinjectionPOLIVY POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 30MG

ES 2 records · 2 strengths

140 mginjectionPOLIVY also in AU·GB·SG
30 mginjectionPOLIVY also in AU·GB

HK 2 records · 1 strengths

Records without a stated strength · 1 POLIVY POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 30MG

TW 1 records · 1 strengths

Records without a stated strength · 1 POLIVY、保癌寧凍晶注射劑

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 POLIVY

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.